1072875-07-0Relevant academic research and scientific papers
OXO-IMIDAZOLIDINES AS MODULATORS OF CHEMOKINE RECEPTORS
-
Page/Page column 21, (2008/12/04)
Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment
MONOCYCLIC AND BICYCLIC COMPOUNDS AND METHODS OF USE
-
Page/Page column 93, (2010/11/26)
Compounds are provided that act as potent antagonists of the CCR1 receptor, and have in vivo anti-inflammatory activity. The compounds are generally monocyclic and bicyclic compounds and are useful in pharmaceutical compositions, methods for the treatment of CCR1-mediated diseases, and as controls in assays for the identification of competitive CCR1 antagonists.
